Biogennix launches Agilon Surgical Matrix

image credit- shutterstock

Biogennix, an osteobiologics company specializing in innovative healing solutions for surgical procedures, announced the launch of its new Agilon Surgical Matrix wound care product.

Agilon Surgical Matrix is a wound care solution derived from hundred percent bovine Type 1 collagen. Upon contact with a new or open wound, whether surgically or naturally occurring, Agilon Surgical Matrix transforms into a gel, enveloping the entire wound area. This coverage maintains a low pH wound environment that aids in the formation of tissue and epithelialization, which is conducive to successful wound healing.

Backed by in vitro performance data, Agilon Surgical Matrix demonstrates wide-ranging antimicrobial properties, offering added protection against infections. The product’s versatility extends to various surgical applications, serving as an alternative to close-suction drains, blood vessel ligation, or surgical site immobilization in preventing postoperative seromas.

With its sterile, single-use packaging, Agilon Surgical Matrix provides a safe and effective option for healthcare professionals and patients. Agilon Surgical Matrix can be used in the management of partial and full thickness wounds, pressure (stage I – IV) and venous ulcers, ulcers caused by mixed vascular etiologies, venous stasis and diabetic ulcers, first and second-degree burns, cuts, abrasions, and surgical wounds. Surgical areas include orthopedic, podiatry, cardiovascular, abdominal, neurologic, plastic/breast reconstruction, general, OB/GYN, trauma, vascular, burns, and ulcers.